Trials / Completed
CompletedNCT00567983
Topical Cyclosporine and Disease Progression
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Restasis | Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily |
| DRUG | Endura | Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2007-12-05
- Last updated
- 2008-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00567983. Inclusion in this directory is not an endorsement.